A Canadian-Made COVID-19 Vaccine Could Be Submitted For Approval By This Summer
Medicago recently started a 30,000-person trial of the vaccine.
A spokesperson for Canada-based company Medicago says it expects to submit its own COVID-19 vaccine for Health Canada approval by the summer.
The company just published a report of its Stage 2 trials for the vaccine, which it says had "positive results" for trialists of all ages, and it has started a Stage 3 trial with up to 30,000 subjects in North America, Latin America and Europe.*
"We expect to have enrolled all participants in our Phase 3 clinical trials by end of spring and be able to analyze and publish the data early summer, at which point we would submit for regulatory approval from Health Canada," a spokesperson from Medicago, which is based out of Quebec City, told Narcity over email.
Medicago reported no related severe adverse effects during Stage 2 of its vaccine trial, and the company said that people who received two doses of its vaccine had "neutralizing antibody responses" that were 10 times higher than people recovering from COVID-19.
The company started a "rolling submission" with Health Canada back in April 2021, which means the approval body can review Medicago's data as it comes in rather than all at once.
*This article has been updated.
- Canadian COVID-19 Vaccine Is Being Reviewed By Health Canada ... ›
- What To Expect After A COVID-19 Vaccine? Canada Has Advice ... ›